AN UNBIASED VIEW OF PHARMACEUTICAL RAW MATERIALS/CHEMICALS

This kind of carryover must not result in the carryover of degradants or microbial contamination which could adversely alter the established API impurity profile.The manufacturing approach begins Together with the synthesis with the active ingredient, wherever chemical reactions are diligently managed to produce the specified compound.Computer syst